| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCRESAHA.109.199059 |
| P8608 | Fatcat ID | release_o6ekhqsybbadtdluxrjuibieqq |
| P932 | PMC publication ID | 3635679 |
| P698 | PubMed publication ID | 19762684 |
| P50 | author | Maria B Grant | Q88523403 |
| Timothy J Lyons | Q88763447 | ||
| Aqeela Afzal | Q42843306 | ||
| Tailoi Chan-Ling | Q54918180 | ||
| Julia V Busik | Q57370590 | ||
| P2093 | author name string | Jun Cai | |
| Michael E Boulton | |||
| Kenneth Wilson | |||
| Arturo J Cardounel | |||
| Jennifer L Kielczewski | |||
| Jeffrey Hughes | |||
| Lynn C Shaw | |||
| Sergio Li Calzi | |||
| Kyung Hee Chang | |||
| Yagna P R Jarajapu | |||
| Robert N Mames | |||
| Todd Lydic | |||
| Evan L McFarland | |||
| P2860 | cites work | Glial, vascular, and neuronal cytogenesis in whole-mounted cat retina | Q73069067 |
| Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription | Q73269991 | ||
| The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor | Q73575408 | ||
| Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin | Q74315649 | ||
| Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice | Q82983956 | ||
| An endothelial receptor for oxidized low-density lipoprotein | Q24323462 | ||
| Transferrin is an insulin-like growth factor-binding protein-3 binding protein | Q28211839 | ||
| Cellular actions of the insulin-like growth factor binding proteins | Q28216659 | ||
| Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes | Q28250539 | ||
| Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways | Q28271357 | ||
| High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I | Q28591194 | ||
| Electrospray mass spectrometry of phospholipids | Q30732919 | ||
| The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization | Q31017364 | ||
| Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization | Q33232494 | ||
| The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism | Q33901922 | ||
| New roles for astrocytes: Regulation of synaptic transmission | Q34266798 | ||
| IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. | Q35973404 | ||
| IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development | Q35973411 | ||
| HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. | Q36056673 | ||
| Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes | Q36842645 | ||
| Molecular control of blood flow and angiogenesis: role of nitric oxide | Q37561414 | ||
| High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase | Q38299352 | ||
| Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo | Q40401160 | ||
| Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells | Q40687906 | ||
| Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis | Q40835429 | ||
| Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity | Q41292409 | ||
| Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions | Q42090948 | ||
| Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells | Q43654508 | ||
| Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis | Q43852817 | ||
| Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis | Q44081378 | ||
| Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells | Q44440538 | ||
| Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity | Q47310528 | ||
| Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation | Q47664130 | ||
| Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. | Q55042012 | ||
| Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone | Q70146330 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| P433 | issue | 9 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 897-905 | |
| P577 | publication date | 2009-09-17 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation | |
| P478 | volume | 105 |
| Q55293851 | A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases. |
| Q34116819 | Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx |
| Q27013698 | An ocular view of the IGF-IGFBP system |
| Q42236025 | Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3. |
| Q34465434 | Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration |
| Q47592483 | Beneficial Effects Of Angiotensin-(1-7) On Cd34 + Cells From Heart Failure Patients |
| Q36687280 | Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina |
| Q35221390 | Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells |
| Q36802005 | Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury |
| Q28552739 | Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion |
| Q36041947 | Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels |
| Q37780204 | Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction |
| Q36807922 | DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose |
| Q26826908 | Endothelial cells and the IGF system |
| Q35947546 | Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing |
| Q26823609 | Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy |
| Q34433667 | Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits |
| Q36808421 | Examining the role of lipid mediators in diabetic retinopathy |
| Q34022792 | Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). |
| Q34355975 | Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans |
| Q35221114 | Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model |
| Q28237971 | IGF binding proteins in cancer: mechanistic and clinical insights |
| Q36516159 | IGF-Binding Proteins in Type-1 Diabetes Are More Severely Altered in the Presence of Complications |
| Q82771605 | IGFBP-3 inhibits the proliferation of neural progenitor cells |
| Q47270202 | IGFBP3 deposited in the human umbilical cord mesenchymal stem cell-secreted extracellular matrix promotes bone formation. |
| Q37264739 | IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses |
| Q36910839 | Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice. |
| Q39605996 | In vivo anti-tumor effect of expressing p14ARF-TAT using a FGF2-targeted cationic lipid vector |
| Q42268694 | Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse |
| Q35857746 | Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis |
| Q33938298 | Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid |
| Q36533065 | Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity |
| Q36300954 | Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma |
| Q34979016 | Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases |
| Q37172543 | Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model |
| Q35436829 | Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice |
| Q36044670 | MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy |
| Q58110029 | Mitochondrial Depolarization Stimulates Vascular Repair-Relevant Functions of CD34 Cells via Reactive Oxygen Species-Induced Nitric Oxide Generation |
| Q49574913 | Models of retinal diseases and their applicability in drug discovery. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q34805398 | Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. |
| Q37258163 | Nutrition, insulin-like growth factor-1 and retinopathy of prematurity |
| Q51166049 | Permanent atrial fibrillation impairs the function of circulating endothelial progenitor cells. |
| Q33585478 | Promoting vascular repair in the retina: can stem/progenitor cells help? |
| Q34335696 | Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. |
| Q101476339 | Rapid response to the alpha-1 adrenergic agent phenylephrine in the perioperative period is impacted by genomics and ancestry |
| Q37927102 | Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. |
| Q30495106 | The mouse retina as an angiogenesis model |
| Q54999086 | The progress of prophylactic treatment in retinopathy of prematurity. |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q34024355 | Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions |
| Q96768569 | Tryptophanyl-tRNA Synthetase, a Novel Damage-Induced Cytokine, Significantly Increases the Therapeutic Effects of Endometrial Stem Cells |
| Q54944394 | Unique and shared inflammatory profiles of human brain endothelia and pericytes. |
| Q35142725 | Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms |
Search more.